Blog It is clear to me that many if not all individuals with Gadolinium Deposition Disease (GDD) have some genetic/epigenetic variant that makes them more susceptible to getting the disease in the first place. I think for your knowledge to know what your particular genetic/epigenetic status is, is of importance to you. I suspect at the present time there may not be evidence-based treatments for many of these variants, but they may arise in the future. Furthermore this provide

heavy metal chelation therapy strategy This is a recent email exchange that I have just had with a patient. Unlike treatment for essentially everything else, treatment duration is self-guided by the sufferer themselves. This is based on their appreciation of re-equilibration Flare. This is not used for infection or cancer where treatment generally involves a set regimen of duration. The reason is that Gd is not a replicating forein invader, so unlike infection, if you stop t

THe Holy Grail It is not accidental to use the concept of the Holy Grail, as it is considered a symbol of some form of perfection, and yet it is elusive, and probably does not exist. But has been used repeatedly and successfully in stories from King Arthur, to Tom Hanks DaVinci Code to Indiana Jones and the Last Crusade. So Evidence-based is the current most popular concept for truth, perfection, fact, reality, etc, in Medicine. this could be termed the Medical Truth. It is

political efforts for imaging I read the below article in Aunt Minnie Europe posted 7/7/2026 talking about the need to continue hunting for an answer with imaging through persistence. 99% wasn't enough: How persistence in imaging changes the picture Two patient stories told at the European Parliament proved that a second look can change everything. This charged my memory about blogs I was thinking about writing regarding: a book that a woman recently wrote describing how

Flare reactions Types of Flare Reactions and Their Management Following DTPA Chelation Introduction A Flare reaction is a temporary increase in the symptoms of heavy-metal toxicity occurring during or following chelation. The phenomenon has been most extensively observed in patients with Gadolinium Deposition Disease undergoing intravenous DTPA chelation. Similar reactions have also been observed in a smaller number of patients undergoing treatment for lead toxicity. A compar